Antibody response six months after the booster dose of Pfizer in previous recipients of CoronaVac

alexandrossfakianakis shared this article with you from Inoreader Antibody response six months after the booster dose of Pfizer in previous recipients of CoronaVac via Journal of Medical Virology Abstract The most widely used vaccines were mRNA, viral vector, and inactivated virus with two-dose schedules. In Brazil, the CoronaVac (Sinovac) was the first vaccine approved for emergency use and the third dose was administered, preferably, with the BNT162b2 vaccine. We evaluated antibody levels after six months of the booster dose with BNT162B2 in previous recipients of CoronaVac and whether a subsequent SARS-COV-2 infection enhances the antibody response. We analyze of the humoral response, S IgM for the SARS-CoV-2, S IgG and N IgG in samples collected before the third dose and six months after the third dose. The presence of antibodies was measured by using Abbott Architect i2000SR. The IgM and IgG anti-spike were stimulated mainly in 30D/3D with a decline over time. The IgG anti-N was stimulated predominantly in 90/3D and 180/3D. The N IgG levels were 50 and 35 times higher in the positive PCR group in 90/3D and 180/3D, respectively. The S IgG titers were 1.5 times elevated in the positive PCR group, in 180/3D. The BNT162b2 boosted the S IgG levels, decreasing after the 60 days. The booster shot induced IgM and IgG antibodies against Spike protein. Infection after vaccination increased antibodies against protein N. This article is protected by copyright. All rights reserved. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.